Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer (Q33330493)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer |
scientific article |
Statements
1 reference
Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer (English)
1 reference
J Nemunaitis
1 reference
J T Holmlund
1 reference
M Kraynak
1 reference
D Richards
1 reference
J Bruce
1 reference
N Ognoskie
1 reference
T J Kwoh
1 reference
R Geary
1 reference
A Dorr
1 reference
D Von Hoff
1 reference
S G Eckhardt
1 reference
1 November 1999
1 reference
1 reference
Identifiers
1 reference